Mika A. Sovak

Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma

James Larkin, Paolo A. Ascierto, Brigitte Dréno et al. · New England Journal of Medicine · 2014 · 2K citations · Full text

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Carol Aghajanian, Stephanie V. Blank, Barbara A. Goff et al. · Journal of Clinical Oncology · 2012 · 1.4K citations · Full text

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

Mika A. Sovak, Robert E. Bellas, Dong Wook Kim et al. · Journal of Clinical Investigation · 1997 · 715 citations · Full text

Breast Oncology, Pathology, Cell Death +16

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial

Jonathan A. Ledermann, Philipp Harter, Charlie Gourley et al. · The Lancet Oncology · 2016 · 444 citations · Full text

Overall Survival, Medicine, Metronomic Therapy +10

Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation

Marcello Arsura, Ganesh R. Panta, Jennifer D. Bilyeu et al. · Oncogene · 2003 · 141 citations

Tak1/ikk Kinase Pathway, Tumor Biology, Signal Transduction +12